225 related articles for article (PubMed ID: 22854025)
1. Prognostic impact of vitamin B6 metabolism in lung cancer.
Galluzzi L; Vitale I; Senovilla L; Olaussen KA; Pinna G; Eisenberg T; Goubar A; Martins I; Michels J; Kratassiouk G; Carmona-Gutierrez D; Scoazec M; Vacchelli E; Schlemmer F; Kepp O; Shen S; Tailler M; Niso-Santano M; Morselli E; Criollo A; Adjemian S; Jemaà M; Chaba K; Pailleret C; Michaud M; Pietrocola F; Tajeddine N; de La Motte Rouge T; Araujo N; Morozova N; Robert T; Ripoche H; Commo F; Besse B; Validire P; Fouret P; Robin A; Dorvault N; Girard P; Gouy S; Pautier P; Jägemann N; Nickel AC; Marsili S; Paccard C; Servant N; Hupé P; Behrens C; Behnam-Motlagh P; Kohno K; Cremer I; Damotte D; Alifano M; Midttun O; Ueland PM; Lazar V; Dessen P; Zischka H; Chatelut E; Castedo M; Madeo F; Barillot E; Thomale J; Wistuba II; Sautès-Fridman C; Zitvogel L; Soria JC; Harel-Bellan A; Kroemer G
Cell Rep; 2012 Aug; 2(2):257-69. PubMed ID: 22854025
[TBL] [Abstract][Full Text] [Related]
2. Vitamin B6 metabolism influences the intracellular accumulation of cisplatin.
Galluzzi L; Marsili S; Vitale I; Senovilla L; Michels J; Garcia P; Vacchelli E; Chatelut E; Castedo M; Kroemer G
Cell Cycle; 2013 Feb; 12(3):417-21. PubMed ID: 23287530
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of LIPC in non-small cell lung carcinoma.
Galluzzi L; Goubar A; Olaussen KA; Vitale I; Senovilla L; Michels J; Robin A; Dorvault N; Besse B; Validire P; Fouret P; Behrens C; Wistuba II; Soria JC; Kroemer G
Cell Cycle; 2013 Feb; 12(4):647-54. PubMed ID: 23343765
[TBL] [Abstract][Full Text] [Related]
4. Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses.
Galluzzi L; Vacchelli E; Michels J; Garcia P; Kepp O; Senovilla L; Vitale I; Kroemer G
Oncogene; 2013 Oct; 32(42):4995-5004. PubMed ID: 23334322
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
6. Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancer.
Michels J; Adam J; Goubar A; Obrist F; Damotte D; Robin A; Alifano M; Vitale I; Olaussen KA; Girard P; Cremer I; Castedo M; Soria JC; Kroemer G
Ann Oncol; 2015 Dec; 26(12):2470-7. PubMed ID: 26387143
[TBL] [Abstract][Full Text] [Related]
7. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
[TBL] [Abstract][Full Text] [Related]
8. CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer.
Li Y; He LR; Gao Y; Zhou NN; Liu Y; Zhou XK; Liu JF; Guan XY; Ma NF; Xie D
Cell Death Dis; 2019 Feb; 10(2):99. PubMed ID: 30718500
[TBL] [Abstract][Full Text] [Related]
9. PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway.
Bai Y; Liu X; Qi X; Liu X; Peng F; Li H; Fu H; Pei S; Chen L; Chi X; Zhang L; Zhu X; Song Y; Wang Y; Meng S; Jiang T; Shao S
EBioMedicine; 2019 Apr; 42():311-325. PubMed ID: 30922965
[TBL] [Abstract][Full Text] [Related]
10. FATS expression is associated with cisplatin sensitivity in non small cell lung cancer.
Tian Y; Zhang J; Yan S; Qiu L; Li Z
Lung Cancer; 2012 Jun; 76(3):416-22. PubMed ID: 22137560
[TBL] [Abstract][Full Text] [Related]
11. MDMX is a prognostic factor for non-small cell lung cancer and regulates its sensitivity to cisplatin.
Zhao H; Xie YZ; Xing R; Sun M; Chi F; Zeng YC
Cell Oncol (Dordr); 2017 Aug; 40(4):357-365. PubMed ID: 28567715
[TBL] [Abstract][Full Text] [Related]
12. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.
Wu Z; Liu Z; Jiang X; Mi Z; Meng M; Wang H; Zhao J; Zheng B; Yuan Z
J Exp Clin Cancer Res; 2019 Aug; 38(1):341. PubMed ID: 31387622
[TBL] [Abstract][Full Text] [Related]
13. The role of expression and polymorphism of the BAG-1 gene in response to platinum-based chemotherapeutics in NSCLC.
Wang YD; Ha MW; Cheng J; Zhang WL; Cong X; Tong CY; Sun J
Oncol Rep; 2012 Apr; 27(4):979-86. PubMed ID: 22179630
[TBL] [Abstract][Full Text] [Related]
14. Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2.
Ko JC; Su YJ; Lin ST; Jhan JY; Ciou SC; Cheng CM; Chiu YF; Kuo YH; Tsai MS; Lin YW
Lung Cancer; 2010 Aug; 69(2):155-64. PubMed ID: 19962780
[TBL] [Abstract][Full Text] [Related]
15. SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancer.
Li J; Zhao L; Pan Y; Ma X; Liu L; Wang W; You W
Int J Oncol; 2020 Sep; 57(3):756-766. PubMed ID: 32705243
[TBL] [Abstract][Full Text] [Related]
16. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
[TBL] [Abstract][Full Text] [Related]
17. Molecular Analysis of
Ye Q; Mohamed R; Dakhlallah D; Gencheva M; Hu G; Pearce MC; Kolluri SK; Marsh CB; Eubank TD; Ivanov AV; Guo NL
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916522
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase 9 downregulation decreases tumor growth and promotes apoptosis in non-small cell lung cancer after melatonin treatment.
Ma Z; Liu D; Di S; Zhang Z; Li W; Zhang J; Xu L; Guo K; Zhu Y; Li X; Han J; Yan X
J Pineal Res; 2019 Sep; 67(2):e12587. PubMed ID: 31090223
[TBL] [Abstract][Full Text] [Related]
19. KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma.
Wang B; Jing T; Jin W; Chen J; Wu C; Wang M; Liu Y
J Exp Clin Cancer Res; 2020 Aug; 39(1):170. PubMed ID: 32854746
[TBL] [Abstract][Full Text] [Related]
20. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
Gao J; Meng Q; Zhao Y; Chen X; Cai L
BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
